Home Cart Sign in  
Chemical Structure| 175137-46-9 Chemical Structure| 175137-46-9

Structure of 175137-46-9

Chemical Structure| 175137-46-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 175137-46-9 ]

CAS No. :175137-46-9
Formula : C6H9N3
M.W : 123.16
SMILES Code : NC1=NNC(C2CC2)=C1
MDL No. :MFCD00067985
InChI Key :MXVAGCQKBDMKPG-UHFFFAOYSA-N
Pubchem ID :2758014

Safety of [ 175137-46-9 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319
Precautionary Statements:P305+P351+P338

Computational Chemistry of [ 175137-46-9 ] Show Less

Physicochemical Properties

Num. heavy atoms 9
Num. arom. heavy atoms 5
Fraction Csp3 0.5
Num. rotatable bonds 1
Num. H-bond acceptors 1.0
Num. H-bond donors 2.0
Molar Refractivity 35.46
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

54.7 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

0.79
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

0.44
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

0.81
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

0.52
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

1.32
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

0.78

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-1.23
Solubility 7.32 mg/ml ; 0.0594 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-1.16
Solubility 8.59 mg/ml ; 0.0697 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-1.43
Solubility 4.58 mg/ml ; 0.0372 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-6.74 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

1.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

0.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

1.89

Application In Synthesis of [ 175137-46-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 175137-46-9 ]

[ 175137-46-9 ] Synthesis Path-Downstream   1~4

  • 1
  • [ 175137-46-9 ]
  • [ 35265-82-8 ]
  • [ 927679-31-0 ]
YieldReaction ConditionsOperation in experiment
82% With triethylamine; In DMA; at 120℃; Compound 4e was made from compound 4d (10.11 g, 46.13 mmol) and compound 1d (5.68 g, 46.13 mmol) using the same procedure of making compound 1e, 2-chloro-Lambda/-(5- cyclopropyl-1H-pyrazol-3-yl)thieno[3,2-d]pyrimidin-4-amine, from compound 1c and compound 1d. The title compound 4e was obtained as an off-white solid. (11.55g, 82%). 1H NMR (400MHz, DMSOd6): delta 0.68-0.72 (m, 2H), 0.92-0.96 (m, 2H), 1.88-1.95 (m, 1 H), 2.55 (s, 3H), 6.18 (S, 1H), 7.07 (s, 1 H), 10.29 (s, 1 H), 12.38 (s, 1 H). LCMS 306 (M+H). Anal. Calcd. For C13H12N5SCI.0.05 H2O.0.1 Et2O C, 51.24; H, 4.20; N, 22.30. Found: C, 51.20; H, 4.27; N, 22.05.
  • 2
  • [ 109-01-3 ]
  • [ 175137-46-9 ]
  • [ 108-77-0 ]
  • [ 68285-27-8 ]
  • [ 1258212-05-3 ]
YieldReaction ConditionsOperation in experiment
Example 20To a solution of cyanuric chloride (230 mg, 1.25 mmol) in THF (16 mL) was added A- fluorophenyl-2-ethylamine (0.16 mL, 1.25 mmol) and DIPEA (0. 20 mL, 1.25 mmol) at 0 C. The reaction mixture was let to stir at 0 C to room temperature for 2h. 3- cyclopropyl-1-H-pyrazol-5-amine (154 mg, 1.25 mmol) and DIPEA (0.20 mL, 1.25 mmol) were added to the above mixture and the resulting mixture was heated with microwave initiator at 150 C for 10 minutes. 1-methylpiperazine (0.28 mL, 2.50 mmol) and DIPEA (0.44 mL, 2.50 mmol) were added to the mixture and the mixture was heated with microwave initiator at 60 C for 10 minutes. Saturated NaHCO3 in water was added and the mixture was extracted by ethyl acetate (3 x 50 mL). The combined organic was washed by brine, dried over sodium sulfate and concentrated. The residue was chromatographed on a silica gel column eluted with 0-5 % MeOH/DCM afforded 20 as off white solid (135 mg, 25 %). 1H NMR (400 MHz, DMSOd6) delta 8.18 (d, 1H, NH), 7.42-6.76 (m, 5Eta, Ar-H), 5.10-5.03 (m, 1Eta, CH), 3.73-3.66 (m, 4Eta, 2CH2), 2.33-2.30 (m, 4Eta, 2CH2), 2.19 (s, 3Eta, CH3), 1.77-1.70 (m, 1Eta, CH), 1.41 (d, 3Eta, CH3), 0.83-0.80 (m, 2Eta, Ar-H), 0.60-0.58 (m, 2Eta, Ar-H) ; ESI-MS: calcd for (C22Eta28FN9) 437, found 438[M+H]+. HPLC: retention time: 7.80 min. purity: 94%.
  • 3
  • [ 175137-46-9 ]
  • [ 105763-77-7 ]
  • 2-(azepan-1-yl)-N-(3-cyclopropyl-1H-pyrazol-5-yl)-6-methoxyquinazolin-4-amine [ No CAS ]
  • 4
  • [ 175137-46-9 ]
  • [ 105763-77-7 ]
  • 2-chloro-N-(3-cyclopropyl-1H-pyrazol-5-yl)-6-methoxyquinazolin-4-amine [ No CAS ]
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 175137-46-9 ]

Amines

Chemical Structure| 326827-21-8

A258874 [326827-21-8]

3-Amino-5-cyclobutyl-1H-pyrazole

Similarity: 0.93

Chemical Structure| 82560-12-1

A105905 [82560-12-1]

3-Amino-5-tert-butylpyrazole

Similarity: 0.92

Chemical Structure| 126748-58-1

A143688 [126748-58-1]

5-Propyl-1H-pyrazol-3-amine

Similarity: 0.92

Chemical Structure| 150712-24-6

A172084 [150712-24-6]

5-Benzyl-1H-pyrazol-3-amine

Similarity: 0.81

Chemical Structure| 31230-17-8

A256524 [31230-17-8]

5-Methyl-1H-pyrazol-3-amine

Similarity: 0.77

Related Parent Nucleus of
[ 175137-46-9 ]

Pyrazoles

Chemical Structure| 326827-21-8

A258874 [326827-21-8]

3-Amino-5-cyclobutyl-1H-pyrazole

Similarity: 0.93

Chemical Structure| 82560-12-1

A105905 [82560-12-1]

3-Amino-5-tert-butylpyrazole

Similarity: 0.92

Chemical Structure| 126748-58-1

A143688 [126748-58-1]

5-Propyl-1H-pyrazol-3-amine

Similarity: 0.92

Chemical Structure| 150712-24-6

A172084 [150712-24-6]

5-Benzyl-1H-pyrazol-3-amine

Similarity: 0.81

Chemical Structure| 31230-17-8

A256524 [31230-17-8]

5-Methyl-1H-pyrazol-3-amine

Similarity: 0.77